'I'm a dementia expert – these are the most common signs to watch for'
An expert has shared the signs of dementia to watch for (Image: Getty)
A dementia expert has shared the signs and symptoms of people should watch for. Around one million people are living with dementia in the UK, but a third do not have a diagnosis.
Hollie Wynde from Alzheimer's Society's Dementia Support Line has broken down what people need to know about dementia. This Dementia Action Week (19-25 May), Alzheimer's Society encouraging people to seek help if they spot these signs in themselves or a loved one.
Dementia is a group of symptoms and is caused by different diseases that damage the brain. It is progressive, which means symptoms may be relatively mild at first, but they get worse over time.
It can affect memory, problems with language and understanding, changes in behaviour and lead to confusion and needing help with daily tasks. Dementia is not a natural part of ageing and is caused when nerve cells in the brain are damaged.
Nerve cells carry messages between different parts of the brain, and to other parts of the body. As more nerve cells are damaged, the brain becomes less able to work properly. Signs of dementia to watch for (Image: Getty)
Dementia can be caused by many different diseases. These diseases affect the brain in different ways, resulting in different types of dementia. Lifestyle, age, genetics and overall health all play a role. Read More Novel electrochemical sensor detects dangerous bacteria
According to Hollie, different types of dementia affect people differently, especially in the early stages. There are, however, some common early signs and symptoms of dementia. Hollie says these include: Memory loss
Difficulty organising thoughts or staying focused
Problems using words or communicating
Problems with vision
Getting confused about where you are or what time it is
Changes in mood or personality
People often start to forget things more as they get older, but for someone with dementia, changes will be different, more serious and will affect their life more. If you're worried about yourself, or someone close to you, you can check your symptoms using Alzheimer's Society's symptom checklist.
There are over 200 subtypes of dementia, but Alzheimer's disease is the most common. Around two out of three people living with dementia in the UK have Alzheimer's disease.
Alzheimer's disease starts in the brain for years before symptoms start to show. Early symptoms are mild and don't stop someone doing their normal everyday activities. When symptoms progress later, this is when it becomes severe enough to be called 'dementia'.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Rosemary has been linked to better memory, lower anxiety and even protection from Alzheimer's
Rosemary (Rosmarinus officinalis), the aromatic herb native to the Mediterranean, has long been treasured in kitchens around the world. But beyond its culinary charm, rosemary is also gaining recognition for its impressive health benefits, especially when it comes to brain health, inflammation and immune function. Research suggests rosemary may even hold promise in the fight against Alzheimer's disease, the leading cause of dementia worldwide. Historically, rosemary has been linked to memory and mental clarity. In ancient Greece and Rome, students and scholars used rosemary in the hope of sharpening concentration and recall. Modern science is finding there may have been something in this: in one study, people who inhaled rosemary's scent performed better on memory tasks compared to those in an unscented environment. So how does rosemary work on the brain? There are several mechanisms at play. For starters, rosemary stimulates blood circulation, including to the brain, helping deliver more oxygen and nutrients, which may improve mental clarity. It also has calming properties; some studies suggest its aroma can reduce anxiety and improve sleep. Lower stress can mean better focus and memory retention. Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences. Rosemary contains compounds that interact with the brain's neurotransmitters. One such compound, 1,8-cineole, helps prevent the breakdown of acetylcholine, a brain chemical essential for learning and memory. By preserving acetylcholine, rosemary may help support cognitive performance, especially as we age. Another bonus? Rosemary is packed with antioxidants, which help protect brain cells from damage caused by oxidative stress – a major factor in cognitive decline. Rosemary is rich in phytochemicals, plant compounds with health-enhancing effects. One of the most powerful is carnosic acid, an antioxidant and anti-inflammatory agent that helps shield brain cells from harm, particularly from the kinds of damage linked to Alzheimer's disease. Read more: In 2025, researchers developed a stable version of carnosic acid called diAcCA. In promising pre-clinical studies, this compound improved memory, boosted the number of synapses (the connections between brain cells), and reduced harmful Alzheimer's related proteins like amyloid-beta and tau. What's especially exciting is that diAcCA only activates in inflamed brain regions, which could minimise side effects. So far, studies in mice show no signs of toxicity and significant cognitive improvements – raising hopes that human trials could be next. Researchers also believe diAcCA could help treat other inflammatory conditions, such as type 2 diabetes, cardiovascular disease and Parkinson's disease. Rosemary's benefits could extend well beyond the brain. It's been used traditionally to ease digestion, relieve bloating and reduce inflammation. Compounds like rosmarinic acid and ursolic acid are known for their anti-inflammatory effects throughout the body. Rosemary may even benefit the skin – a review suggests it can help soothe acne and eczema, while carnosic acid may offer anti-ageing benefits by protecting skin from sun damage. Rosemary oil also has antimicrobial properties, showing promise in food preservation and potential pharmaceutical applications by inhibiting the growth of bacteria and fungi. For most people, rosemary is safe when used in food, teas or aromatherapy. But concentrated doses or extracts can pose risks. Consuming large amounts may cause vomiting or, in rare cases, seizures – particularly in people with epilepsy. There's also a theoretical risk of rosemary stimulating uterine contractions, so pregnant people should avoid high doses. Because rosemary can interact with some medications – such as blood thinners – it's best to check with a healthcare provider before taking large amounts in supplement form. Rosemary is more than just a kitchen staple. It's a natural remedy with ancient roots and modern scientific backing. As research continues, particularly into breakthrough compounds like diAcCA, rosemary could play an exciting role in future treatments for Alzheimer's and other chronic conditions. In the meantime, adding a little rosemary to your life – whether in a meal, a cup of tea, or a breath of its fragrant oil – could be a small step with big health benefits. This article is republished from The Conversation under a Creative Commons license. Read the original article. Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
New York Post
7 hours ago
- New York Post
People who eat certain type of diet are at low risk for dementia, research shows
Certain foods may feed the brain better than others. New research presented this week at NUTRITION 2025, the annual meeting of the American Society for Nutrition in Orlando, Florida, found that the MIND diet is particularly beneficial for cognitive health. Advertisement People who followed the MIND eating plan — which stands for Mediterranean-DASH Intervention for Neurodegenerative Delay — were 'significantly less likely' to develop Alzheimer's disease or other forms of dementia, according to a press release from the American Society for Nutrition. What is the MIND diet? MIND is a hybrid of the Mediterranean diet and the DASH diet (Dietary Approaches to Stop Hypertension), the latter of which is designed to reduce blood pressure. The diet focuses on 'brain-healthy foods' like leafy green vegetables, berries, nuts, and olive oil. 'The MIND diet is unique as the first eating plan focused on foods to specifically improve and support cognitive health,' Lauren Harris-Pincus, registered dietitian nutritionist and founder of and author of 'The Everything Easy Pre-Diabetes Cookbook,' told Fox News Digital. Advertisement 5 New research presented this week at NUTRITION 2025 found that the MIND diet is particularly beneficial for cognitive health. bit24 – 5 Those who followed the diet were shown to have an overall 9% reduced risk of dementia. LIGHTFIELD STUDIOS – The plant-focused MIND diet highlights 10 types of food, including berries, leafy greens, veggies, whole grains, nuts and seeds, beans, legumes, seafood, poultry, and olive oil, according to Harris-Pincus, who was not involved in the research. 'These focus foods contain nutrients that play a critical role in supporting brain health, including flavonoids, carotenoids, B vitamins, omega-3 fatty acids (especially DHA), choline, and minerals like magnesium, potassium, and calcium,' she said. Advertisement 'The diet also suggests limiting foods such as pastries, refined sugar, red meat, cheese, fried foods, fast food, and butter or margarine.' 5 The plant-focused MIND diet highlights 10 types of food, including berries, leafy greens, veggies, and whole grains. monticellllo – MIND's impact on brain health Researchers from the University of Hawaii analyzed data from nearly 93,000 U.S. adults who reported their dietary habits during the 1990s as part of the Multiethnic Cohort Study. At the start of the study, participants ranged in age from 45 to 75. Advertisement 5 People who followed the MIND eating plan were 'significantly less likely' to develop Alzheimer's disease or other forms of dementia, according to a press release from the American Society for Nutrition. Jacob Lund – In analyzing which participants developed Alzheimer's or other dementias in later years, the MIND eating plan performed better than other healthy diets in terms of reducing dementia risk, with benefits seen among both younger and older groups. Those who followed the diet were shown to have an overall 9% reduced risk of dementia, and some groups — African American, Latino, and White participants — showed a 13% lower risk. Asian-Americans and native Hawaiians did not show as pronounced a risk reduction. 5 'Our study findings confirm that healthy dietary patterns in mid to late life and their improvement over time may prevent Alzheimer's and related dementias,' said Song-Yi Park (not pictured), PhD, associate professor at the University of Hawaii at Manoa. LIGHTFIELD STUDIOS – The longer people adhered to the diet, the greater the reduction of risk. Those who followed the plan over a 10-year period had a 25% lower risk compared to those who didn't stick with it. 'Our study findings confirm that healthy dietary patterns in mid to late life and their improvement over time may prevent Alzheimer's and related dementias,' said Song-Yi Park, PhD, associate professor at the University of Hawaii at Manoa, in the release. 'This suggests that it is never too late to adopt a healthy diet to prevent dementia.'
Yahoo
7 hours ago
- Yahoo
Acadia Pharmaceuticals to Host R&D Day in New York City on June 25, 2025
SAN DIEGO, June 05, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced it will host a R&D day in New York City to discuss its neurological and rare diseases pipeline on Wednesday, June 25, 2025 at 8:30 AM ET. The event will feature members of Acadia's management team and R&D organization, key opinion leaders (KOL) and members of the caregiver community. To register for the live webcast, please click here. A replay of Acadia's R&D Day will be available on the company's website, under the investors section for approximately 3 months following the event. About Acadia Pharmaceuticals Acadia is advancing breakthroughs in neuroscience to elevate life. Since our founding we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson's disease psychosis and the first and only approved drug in the United States and Canada for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer's disease psychosis and multiple other programs targeting neuroscience and neuro-rare diseases. For more information, visit us at and follow us on LinkedIn and X. View source version on Contacts Investor Contact: Acadia Pharmaceuticals Kildani(858) 261-2872ir@ Acadia Pharmaceuticals Tieszen(858) 261-2950ir@ Media Contact: Acadia Pharmaceuticals Kazenelson(818) 395-3043media@
